본문으로 건너뛰기
← 뒤로

Multi-omics and network pharmacology reveal the mechanisms of Scutellaria barbata D.Don and Scleromitrion diffusum (Willd.) R.J.Wang against pancreatic cancer.

1/5 보강
Scientific reports 2026 Vol.16(1)
Retraction 확인
출처

Zhao Z, Yang Y, Zhang L, He X, Ding K, Chen Y, Huo Y, Li P, Li R, Ali T, Zhao D, Choe H, Ma J, Shang D, Zhang L

📝 환자 설명용 한 줄

Pancreatic cancer (PC) is a common gastrointestinal malignancy whose initiation and progression may be closely linked to the gut microbiota.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Zhao Z, Yang Y, et al. (2026). Multi-omics and network pharmacology reveal the mechanisms of Scutellaria barbata D.Don and Scleromitrion diffusum (Willd.) R.J.Wang against pancreatic cancer.. Scientific reports, 16(1). https://doi.org/10.1038/s41598-026-45676-x
MLA Zhao Z, et al.. "Multi-omics and network pharmacology reveal the mechanisms of Scutellaria barbata D.Don and Scleromitrion diffusum (Willd.) R.J.Wang against pancreatic cancer.." Scientific reports, vol. 16, no. 1, 2026.
PMID 41896653

Abstract

Pancreatic cancer (PC) is a common gastrointestinal malignancy whose initiation and progression may be closely linked to the gut microbiota. Previous research indicates that Scutellaria barbata D. Don and Scleromitrion diffusum (Willd.) R.J. Wang (SB-SD) exhibit diverse biological activities, such as anti-inflammatory, antioxidant, and antitumor effects, though their precise regulatory mechanisms are not fully elucidated. Here, we treated PC cells with SB-SD to assess its impact on cell viability, apoptosis, migration, and cell cycle progression, while Western blotting analyzed the expression of HSP90AA1, MAPK3, p53, CDK1, and p21. We also established a pancreatic cancer xenograft model in nude mice to evaluate the in vivo inhibitory effect of SB-SD on tumor growth. Furthermore, we employed metagenomic sequencing, untargeted metabolomics, and quantitative proteomics to comprehensively profile changes in the gut microbiota, serum metabolites, and differentially expressed proteins, with Western blotting subsequently validating BCKDK, GATM and p53 expression. The results show that SB-SD significantly inhibited PC cell proliferation, promoted apoptosis, and induced S/G2 phase cell cycle arrest, potentially via modulation of the HSP90AA1/MAPK3 signaling pathway. Measurements of tumor volume and weight, complemented by histopathological analysis, confirmed that SB-SD effectively suppressed the growth of PANC-1 xenograft tumors. Integrated multi-omics analyses suggest that the antitumor effects of SB-SD may involve the modulation of key gut microbes like Bacteroides caccae and Lactobacillus, the promotion of choline metabolism, and the regulation of BCKDK and GATM. Together, these findings not only corroborate the direct antitumor activity of SB-SD against pancreatic cancer but also offer novel mechanistic insights by constructing a microbiota-metabolite-protein interaction network.

MeSH Terms

Humans; Animals; Scutellaria; Pancreatic Neoplasms; Mice; Network Pharmacology; Cell Line, Tumor; Apoptosis; Plant Extracts; Xenograft Model Antitumor Assays; Mice, Nude; Cell Proliferation; Gastrointestinal Microbiome; Cell Survival; Cell Movement; Antineoplastic Agents, Phytogenic; Proteomics; Metabolomics; Multiomics

같은 제1저자의 인용 많은 논문 (5)